Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma.
Medina A, Jiménez C, Puig N, Sarasquete ME, Flores-Montero J, García-Álvarez M, Prieto-Conde I, Chillón C, Alcoceba M, González-Calle V, Gutiérrez NC, Jacobsen A, Vigil E, Hutt K, Huang Y, Orfao A, González M, Miller J, García-Sanz R.
Medina A, et al. Among authors: gutierrez nc.
Arch Pathol Lab Med. 2022 Jul 1;146(7):862-871. doi: 10.5858/arpa.2021-0088-OA.
Arch Pathol Lab Med. 2022.
PMID: 34619755
Free article.